Literature DB >> 36066456

Bringing natural killer cells to the clinic.

Laura Chiossone1, Eric Vivier1,2,3.   

Abstract

Cancer is a leading cause of mortality worldwide, with around 10 million deaths every year. Despite huge advances due to immunotherapy, the majority of cancer patients present primary or secondary resistance to these treatments. In this Found in Translation, we focus on the approaches developed to harness the anti-tumor function of NK cells, suggesting promising strategies to complete the therapeutic arsenal of cancer immunotherapies.
© 2022 Chiossone and Vivier.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36066456      PMCID： PMC9448638          DOI： 10.1084/jem.20220830

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   17.579


  32 in total

1.  Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer.

Authors:  Eisuke Kondo; Keiji Koda; Nobuhiro Takiguchi; Kenji Oda; Kazuhiro Seike; Mitsuru Ishizuka; Masaru Miyazaki
Journal:  Dig Surg       Date:  2003-07-31       Impact factor: 2.588

2.  Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.

Authors:  Michaela Semeraro; Sylvie Rusakiewicz; Véronique Minard-Colin; Nicolas F Delahaye; David Enot; Frédéric Vély; Aurélien Marabelle; Benjamin Papoular; Christelle Piperoglou; Mirco Ponzoni; Patrizia Perri; Andrei Tchirkov; Jessica Matta; Valérie Lapierre; Tala Shekarian; Sandrine Valsesia-Wittmann; Frédéric Commo; Nicole Prada; Vichnou Poirier-Colame; Brigitte Bressac; Sophie Cotteret; Laurence Brugieres; Françoise Farace; Nathalie Chaput; Guido Kroemer; Dominique Valteau-Couanet; Laurence Zitvogel
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

3.  Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

Authors:  Simon Pernot; Magali Terme; Nina Radosevic-Robin; Florence Castan; Cécile Badoual; Elie Marcheteau; Fréderique Penault-Llorca; Olivier Bouche; Jaafar Bennouna; Eric Francois; Francois Ghiringhelli; Christelle De La Fouchardiere; Emmanuelle Samalin; Jean Baptiste Bachet; Christophe Borg; Valérie Boige; Thibault Voron; Trevor Stanbury; Eric Tartour; Sophie Gourgou; David Malka; Julien Taieb
Journal:  Gastric Cancer       Date:  2019-07-02       Impact factor: 7.370

4.  Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer.

Authors:  Francisco R Villegas; Santiago Coca; Vicente G Villarrubia; Rodrigo Jiménez; María Jesús Chillón; Javier Jareño; Marcos Zuil; Luis Callol
Journal:  Lung Cancer       Date:  2002-01       Impact factor: 5.705

5.  Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

Authors:  Carsten Denkert; Gunter von Minckwitz; Silvia Darb-Esfahani; Bianca Lederer; Barbara I Heppner; Karsten E Weber; Jan Budczies; Jens Huober; Frederick Klauschen; Jenny Furlanetto; Wolfgang D Schmitt; Jens-Uwe Blohmer; Thomas Karn; Berit M Pfitzner; Sherko Kümmel; Knut Engels; Andreas Schneeweiss; Arndt Hartmann; Aurelia Noske; Peter A Fasching; Christian Jackisch; Marion van Mackelenbergh; Peter Sinn; Christian Schem; Claus Hanusch; Michael Untch; Sibylle Loibl
Journal:  Lancet Oncol       Date:  2017-12-07       Impact factor: 41.316

6.  NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.

Authors:  Aura Muntasell; Federico Rojo; Sonia Servitja; Carlota Rubio-Perez; Mariona Cabo; David Tamborero; Marcel Costa-García; María Martínez-Garcia; Sílvia Menéndez; Ivonne Vazquez; Ana Lluch; Abel Gonzalez-Perez; Ana Rovira; Miguel López-Botet; Joan Albanell
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

7.  Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

Authors:  Christine Pasero; Gwenaëlle Gravis; Mathilde Guerin; Samuel Granjeaud; Jeanne Thomassin-Piana; Palma Rocchi; Maria Paciencia-Gros; Flora Poizat; Mélanie Bentobji; Francine Azario-Cheillan; Jochen Walz; Naji Salem; Serge Brunelle; Alessandro Moretta; Daniel Olive
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

8.  NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.

Authors:  Erin M Sullivan; Sima Jeha; Guolian Kang; Cheng Cheng; Barbara Rooney; Martha Holladay; Rafijul Bari; Sarah Schell; MaCal Tuggle; Ching-Hon Pui; Wing Leung
Journal:  Clin Cancer Res       Date:  2014-10-03       Impact factor: 12.531

Review 9.  Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments.

Authors:  Olivier Demaria; Laurent Gauthier; Guilhaume Debroas; Eric Vivier
Journal:  Eur J Immunol       Date:  2021-06-18       Impact factor: 5.532

10.  NK Cells as Possible Prognostic Factor in Childhood Acute Lymphoblastic Leukemia.

Authors:  Agnieszka Mizia-Malarz; Grażyna Sobol-Milejska
Journal:  Dis Markers       Date:  2019-01-02       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.